**7. Conclusion**

Asia is the world's fastest-growing pharmaceutical market, with enormous potential for drug discovery and marketing. As a result, pharmaceutical regulations in this area are attracting a lot of interest from pharmaceutical companies all over the world. In Asia, pharmaceutical and drug registration is becoming more regulated. Although pharmacovigilance systems in all three countries listed above have made significant progress in recent decades. All pharmacovigilance systems face a common set of ongoing challenges in drug safety surveillance in one of five major interrelated areas: engaging the public, collaborating and partnerships, incorporating informatics, adopting a global approach and assessing the impending danger. These difficulties are not fresh in general. Last but not least, high-level training to increase trained manpower and raising awareness among consumers and HCPs to report as many ADRs as possible would aid in the development of a strong PV system in Asia.

*Introductory Chapter: Pharmacovigilance Regulatory Framework of Three Asian Countries… DOI: http://dx.doi.org/10.5772/intechopen.109194*
